Conditions and clinical importance of the test with propranololume

Conditions and clinical importance of the test with propranololume

It is developed the test with peroral reception of Propranololum and definition Cmax by methods HPLC and a capillary electrophoresis. At patients from an ischemic heart disease the size of the test the is more, than the chronic heart failure is more expressed.

Bibliographic Details
Main Authors:	T S Noskova, A N Fomin, T Yu Shirokova, M M Kuznetsov, M M Smekalova, Yu A Djurko
Format:	Article
Language:	English
Published:	Peoples’ Friendship University of Russia (RUDN University) 2009-12-01
Series:	RUDN Journal of Medicine
Subjects:	пропранолол определение ишемическая болезнь сердца
Online Access:	http://journals.rudn.ru/medicine/article/view/2588

Similar Items

Brain neuro-plasticity, depression, and antidepressant therapy
by: G. V. Pogosova, et al.
Published: (1970-01-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

Cardiological Syndrome X: Diagnosis and Intensive Care
by: Yu. V. Shirokikh, et al.
Published: (2007-08-01)

О ФАКТОРАХ РИСКА, ОСОБЕННОСТЯХ ТЕЧЕНИЯ И КРИТЕРИЯХ ДИАГНОСТИКИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
by: О. Н. Сигитова, et al.
Published: (2013-10-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

Dose-dependent effect of statins on the change in the content of individual fatty acids of blood serum and their complexes of men and women with secondary prevention of chronic coronary heart disease
by: M. Yu. Kotlovsky, et al.
Published: (2018-03-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Prevalence of ischemic heart disease among males with tuberculosis
by: V A Koshechkin, et al.
Published: (2011-09-01)

Effectiveness of lipid-lowering therapy in outpatients with coronary artery disease living in a large industrial center of Eastern Siberia
by: N. G. Gogolashvili, et al.
Published: (2022-01-01)

Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
by: V. V. Novitsky, et al.
Published: (2008-09-01)

EVALUATION OF MYOCARDIAL REVASCULARIZATION IN STABLE CORONARY HEART DISEASE PATIENTS AND FACTORS ASSOCIATED WITH INVASIVE STRATEGY CHOICE
by: A. S. Korotin, et al.
Published: (2017-08-01)

Suture annuloplasty for surgical treatment of ischemic mitral regurgitation: long-term results
by: М. Л. Гордеев, et al.
Published: (2015-10-01)

ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ МИТРАЛЬНОЙ НЕДОСТАТОЧНОСТИ ИШЕМИЧЕСКОГО ГЕНЕЗА
Published: (2018-01-01)

The specific features of the diagnosis and treatment of coronary heart disease in rheumatoid arthritis (Results of the authors’ studies)
by: Natalya Anatolyevna Khramtsova, et al.
Published: (2012-06-01)

Left ventricular structural heterogeneity and myocardial remodelling
by: A. M. Naidich
Published: (2006-03-01)

Clinical and pharmaco-economic assessment of ACE inhibitors perindopril and enalapril in coronary heart disease patients after coronary artery bypass graft surgery
by: Yu. M. Lopatin, et al.
Published: (2009-06-01)

DETECTING PAINLESS MYOCARDIAL ISCHEMIA IN A PATIENT WITH RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
by: M. A. Elkanova, et al.
Published: (2016-07-01)

A CLINICAL CASE OF VASOSPASTIC ANGINA IN A PATIENT WITH GASTROESOPHAGEAL REFLUX DISEASE
by: Irina Vladimirovna Ponomarenko, et al.
Published: (2023-09-01)

Sakharnyy diabet i ishemicheskaya bolezn' serdtsa: poiski resheniya
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2005-09-01)

КЛИНИКО-ГЕМОДИНАМИЧЕСКАЯ ХАРАКТЕРИСТИКА ЭФФЕКТИВНОСТИ ЭРАДИКАЦИОННОЙ ТЕРАПИИ У БОЛЬНЫХ С СОЧЕТАНИЕМ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА И ЯЗВЕННОЙ БОЛЕЗНИ
by: Ж. Г. Симонова, et al.
Published: (2014-10-01)

Analysis and evaluation of healthcare delivery to patients with coronary artery disease using PC-based medical data
by: A. M. Nazarov, et al.
Published: (2020-12-01)

THE PROBLEM OF THE OPTIMAL PHARMACOTHERAPY CHOICE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

Relationship between coronary artery calcification and osteopenic syndrome in men with coronary heart disease
by: T. A. Raskina, et al.
Published: (2016-06-01)

State of microcircuiation in cardiac chamber walls in elderly patients with aortic stenosis combined with coronary heart disease
by: A. M. Karaskov, et al.
Published: (2018-06-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
by: A. L. Pirogov, et al.
Published: (2007-10-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Prospective rAndomized, single-blind, mulTicenter control clinical study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-elutIng cOronary stenT “Xience Prime”: design and rationale for “PATRIOT” trial
by: А. А. Прохорихин, et al.
Published: (2016-12-01)

Change in the fatty acids spectrum of erythrocyte in patients with chronic form of coronary heart disease in treatment by Simvastatin
by: V. V. Novitsky, et al.
Published: (2012-02-01)

ECG DISPERSION MAPPING PARAMETERS DURING THE TREADMILL TEST IN PATIENTS WITH CORONARY HEART DISEASE
by: G. G. Ivanov, et al.
Published: (2013-04-01)

DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE
by: S. A. Shalnova, et al.
Published: (2015-09-01)

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

THE EFFECTIVENESS OF MEDICAL REHABILITATION IN CORONARY HEART DISEASE AS A PART OF THE SPA RESORT TREATMENT
by: A. S. Ivashchenko, et al.
Published: (2017-06-01)

Association of smoking with coronary artery disease depending on other cardiovascular risk factors
by: E. D. Bazdyrev, et al.
Published: (2021-04-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation
by: F. T. Ageev, et al.
Published: (2011-06-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Coronary artery status in patients with coronary heart disease and chronic obstructive pulmonary disease: results of selective coronary angiography
by: N. Yu. Grigorieva, et al.
Published: (2012-10-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)